Phase II study of chemotherapy with UFT/LV/Bevacizumab in elderly patients with advanced and recurrent colorectal cancer.
Phase of Trial: Phase II
Latest Information Update: 12 May 2016
At a glance
- Drugs Bevacizumab (Primary) ; Folinic acid (Primary) ; Tegafur/uracil (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 04 Oct 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 04 Feb 2012 New trial record